Carl Zeiss (AFX GY) Q1 (EUR): Revenue 467mln (prev. 490mln), a decline mainly caused by currency effects; EBITA 8mln (prev. 35mln). FY25/26 guidance will likely not be achieved.

Carl Zeiss (AFX GY) Q1 (EUR): Revenue 467mln (prev. 490mln), a decline mainly caused by currency effects; EBITA 8mln (prev. 35mln). FY25/26 guidance will likely not be achieved.

Carl Zeiss reported a Q1 revenue decline primarily due to adverse currency effects, missing previous figures significantly. The drop in EBITA from 35 million to 8 million is particularly concerning, suggesting operational challenges beyond currency impacts. Furthermore, the expectation of not achieving FY25/26 guidance raises red flags for market sentiment and could have implications for the stock's near-term performance.